Retinal vein occlusion

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
S Ophthalmology/ENT (ATC S) 1
Mechanism of action (INN-stem analysis)
Receptor fusion protein 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Alvotech Swiss AG Commercial 1 Phase III 0
Bayer AG Commercial 1 Phase III 0
New trials by year
2023
1
2024
1
← All indication landscapes